-
公开(公告)号:EP2323987B1
公开(公告)日:2015-06-24
申请号:EP09785018.4
申请日:2009-08-29
申请人: University of Dundee
发明人: BRAND, Stephen , WYATT, Paul , THOMPSON, Stephen , HARRISON, Justin , NORCROSS, Neil , GILBERT, Ian , CLEGHORN, Laura , BAYLISS, Tracy , SMITH, Victoria , BRENK, Ruth
IPC分类号: C07D213/75 , C07D213/42 , C07D239/69 , C07D263/50 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04
CPC分类号: C07D231/42 , A61K31/415 , C07D213/75 , C07D239/69 , C07D263/50 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04
摘要: The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors.
-
公开(公告)号:EP3792251B1
公开(公告)日:2024-02-14
申请号:EP20198166.9
申请日:2015-08-27
发明人: TAHTAOUI, Chouaib , GAUVRY, Noëlle
IPC分类号: C07D213/61 , C07C205/11 , C07C311/08 , C07C311/20 , A61P33/10 , A61K31/18 , C07D209/08 , C07D213/84 , C07D213/65 , C07D215/06 , C07D231/56 , C07D239/34 , C07D249/12 , C07D263/50 , C07D275/03 , C07D277/64 , C07D279/12 , C07D295/26 , C07D285/135 , C07D333/78 , C07D487/04
-
公开(公告)号:EP1277729A4
公开(公告)日:2005-05-11
申请号:EP01925984
申请日:2001-04-26
申请人: SANKYO CO
IPC分类号: C07D295/12 , A61K31/166 , A61K31/353 , A61K31/381 , A61K31/40 , A61K31/4184 , A61K31/421 , A61K31/426 , A61K31/427 , A61K31/428 , A61K31/433 , A61K31/44 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4439 , A61K31/4453 , A61K31/455 , A61K31/47 , A61K31/472 , A61K31/495 , A61K31/4965 , A61K31/50 , A61K31/505 , A61K31/5375 , A61P1/16 , A61P1/18 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/14 , A61P7/06 , A61P9/10 , A61P9/12 , A61P19/00 , A61P19/06 , A61P25/28 , A61P29/00 , A61P35/00 , A61P35/02 , A61P37/00 , A61P43/00 , C07C233/65 , C07C233/66 , C07C233/75 , C07C233/80 , C07C233/81 , C07C255/58 , C07C255/60 , C07C271/28 , C07C271/58 , C07C275/14 , C07C275/24 , C07C275/28 , C07C275/40 , C07C275/50 , C07C311/08 , C07C311/13 , C07C311/21 , C07C311/44 , C07C311/46 , C07C311/48 , C07C311/58 , C07C311/64 , C07C335/16 , C07C335/20 , C07C335/26 , C07C335/28 , C07D207/32 , C07D207/325 , C07D211/16 , C07D213/40 , C07D213/75 , C07D213/76 , C07D213/82 , C07D215/38 , C07D215/40 , C07D217/22 , C07D231/14 , C07D231/40 , C07D231/42 , C07D231/56 , C07D235/30 , C07D237/20 , C07D239/42 , C07D239/46 , C07D239/54 , C07D239/545 , C07D239/84 , C07D241/20 , C07D241/26 , C07D243/38 , C07D261/16 , C07D263/48 , C07D263/50 , C07D263/58 , C07D277/20 , C07D277/40 , C07D277/46 , C07D277/50 , C07D277/54 , C07D277/66 , C07D277/82 , C07D285/12 , C07D285/135 , C07D285/14 , C07D295/135 , C07D295/18 , C07D295/185 , C07D295/192 , C07D295/205 , C07D295/215 , C07D295/26 , C07D295/32 , C07D311/22 , C07D311/24 , C07D333/36 , C07D333/38 , C07D333/68 , C07D417/04 , C07D471/04 , C07D521/00
CPC分类号: C07D249/08 , C07C233/65 , C07C233/66 , C07C233/75 , C07C233/80 , C07C233/81 , C07C255/58 , C07C271/28 , C07C275/14 , C07C275/28 , C07C275/40 , C07C275/50 , C07C311/08 , C07C311/21 , C07C311/46 , C07C311/48 , C07C311/58 , C07C311/64 , C07C335/16 , C07C335/20 , C07C335/26 , C07C335/28 , C07C2603/72 , C07D207/325 , C07D213/40 , C07D213/75 , C07D213/76 , C07D213/82 , C07D215/38 , C07D215/40 , C07D217/22 , C07D231/12 , C07D231/14 , C07D231/40 , C07D231/42 , C07D231/56 , C07D233/56 , C07D235/30 , C07D237/20 , C07D239/42 , C07D239/47 , C07D239/545 , C07D241/20 , C07D241/26 , C07D243/38 , C07D261/16 , C07D263/50 , C07D263/58 , C07D277/40 , C07D277/46 , C07D277/50 , C07D277/66 , C07D277/82 , C07D285/135 , C07D285/14 , C07D295/135 , C07D295/185 , C07D295/192 , C07D295/205 , C07D295/215 , C07D295/26 , C07D295/32 , C07D311/24 , C07D333/38 , C07D333/68 , C07D417/04 , C07D471/04
摘要: To provide PPARη modulators seemingly usable in remedies for involutional osteoporosis which inhibit the accelerated differentiation of adipocytes and promote the formation and differentiation of osteoblasts from stem cells, or remedies for diabetes which are free from excessive formation of adipocytes, liver functional failure, vascular lesion, heart failure, etc. Compounds represented by general formula (I) or pharmacologically acceptable salts thereof: wherein A represents phenyl, etc.; B represents aryl, etc.; X represents oxygen, etc.; and n is 0 or 1.
摘要翻译: 本发明的目的是提供一种PPARγ调节剂,其可以是逆行性骨质疏松症的治疗剂,其中脂肪细胞的过度分化被抑制,成骨细胞从干细胞的形成和分化被促进,或者没有诸如过量的特征的糖尿病 脂肪形成,肝功能障碍,血管疾病,心脏病等。 ÄSolutionÜ下列化合物或其药理学上可接受的盐:
其中A表示苯基等,B表示芳基等,X表示氧原子等,n表示0或 1。 -
公开(公告)号:EP0021229B1
公开(公告)日:1982-12-22
申请号:EP80103217.8
申请日:1980-06-10
申请人: PHARMACIA AB
发明人: Agback, Karl Hubert
IPC分类号: C07C107/06 , C07D213/76 , C07D239/69 , C07D263/50 , C07D405/12 , A61K31/655
CPC分类号: C07D213/76 , C07C245/08 , C07D239/69 , C07D263/50
-
公开(公告)号:EP4225737A1
公开(公告)日:2023-08-16
申请号:EP21801354.8
申请日:2021-10-06
发明人: MCCARTNEY, Jason , ABRAHAM, Sunny , ANDERSON, Corey Don , ARUMUGAM, Vijayalaksmi , CHAU, Jaclyn , CLEVELAND, Thomas , DWIGHT, Timothy A. , FRIEMAN, Bryan A. , GROOTENHUIS, Peter , HADIDA RUAH, Sara Sabina , ISHIHARA, Yoshihiro , MILLER, Mark Thomas , SILINA, Alina , ZHOU, Jinglan
IPC分类号: C07D213/72 , C07D231/42 , C07D241/22 , C07D251/24 , C07D261/16 , C07D263/50 , C07D277/52 , C07D279/06 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D417/14 , A61P43/00 , A61K31/415 , A61K31/44 , A61K31/54
-
公开(公告)号:EP3281937A1
公开(公告)日:2018-02-14
申请号:EP16183294.4
申请日:2016-08-09
发明人: DE PIZZOL, Maria , SIRICO, Anna , ZIPPOLI, Mara , BIANCHINI, Gianluca , BECCARI, Andrea , ARAMINI, Andrea , LIBERATI, Chiara Rossana Maria
IPC分类号: C07C311/16 , C07C311/21 , C07C311/51 , C07D231/42 , C07D235/30 , C07D249/04 , C07D249/08 , C07D249/14 , C07D257/06 , C07D261/16 , C07D263/50 , C07D275/03 , C07D277/52 , C07D285/04 , C07D285/135
CPC分类号: C07D231/42 , A61K31/18 , A61K31/41 , A61K31/415 , A61K31/4184 , A61K31/4192 , A61K31/4196 , A61K31/42 , A61K31/425 , A61K31/433 , C07C311/16 , C07C311/21 , C07C311/51 , C07D235/30 , C07D249/04 , C07D249/08 , C07D249/14 , C07D257/06 , C07D261/16 , C07D263/50 , C07D275/03 , C07D277/52 , C07D285/04 , C07D285/135
摘要: The invention relates to compounds acting as agonists of G-protein coupled receptor 120 (GPR120) and/or 40 (GPR40), and having formula (I):
Said compounds are useful in the treatment of diseases or disorders modulated by GPR120 and/or GPR40 such as diabetes (particularly type 2 diabetes), impaired oral glucose tolerance, insulin resistance, obesity, obesity related disorders, metabolic syndrome, dyslipidemia, elevated LDL, elevated triglycerides, obesity induced inflammation, osteoporosis and obesity related cardiovascular disorders.摘要翻译: 本发明涉及用作G蛋白偶联受体120(GPR120)和/或40(GPR40)的激动剂的化合物,并且具有式(I):所述化合物可用于治疗由GPR120调节的疾病或病症和/或 GPR40如糖尿病(特别是2型糖尿病),口服葡萄糖耐量受损,胰岛素抵抗,肥胖,肥胖相关病症,代谢综合征,血脂异常,LDL升高,甘油三酯升高,肥胖诱导的炎症,骨质疏松症和肥胖相关心血管病症。
-
公开(公告)号:EP2385938B1
公开(公告)日:2015-03-04
申请号:EP10702740.1
申请日:2010-01-06
申请人: Pfizer Limited , Icagen, Inc.
发明人: BEAUDOIN, Serge , LAUFERSWEILER, Michael Christopher , MARKWORTH, Christopher John , MARRON, Brian Edward , MILLAN, David Simon , RAWSON, David James , REISTER, Steven Michael , SASAKI, Kosuke , STORER, Robert Ian , STUPPLE, Paul Anthony , SWAIN, Nigel Alan , WEST, Christopher William , ZHOU, Shulan
IPC分类号: C07D263/50 , C07D277/18 , C07D285/08 , C07D413/12 , C07D417/12 , C07D275/03
CPC分类号: C07D417/12 , A61K31/427 , A61K31/433 , A61K31/4439 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/501 , A61K31/506 , A61K31/675 , A61K45/06 , C07D263/50 , C07D275/03 , C07D277/18 , C07D285/08 , C07D401/12 , C07D413/12 , C07D417/14 , C07F9/6539
-
公开(公告)号:EP2980076B1
公开(公告)日:2017-05-31
申请号:EP15156565.2
申请日:2009-08-29
申请人: University of Dundee
发明人: Brand, Stephen , Wyatt, Paul , Thompson, Stephen , Harrison, Justin , Norcross, Neil , Gilbert, Ian , Cleghorn, Laura , Bayliss, Tracy , Smith, Victoria , Brenk, Ruth
IPC分类号: C07D213/75 , C07D231/42 , C07D239/69 , C07D263/50 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04 , A61K31/4155 , A61K31/422 , A61K31/496 , A61K31/4439 , A61K31/506 , A61P25/00 , A61P31/00 , A61P35/00
CPC分类号: C07D231/42 , A61K31/415 , C07D213/75 , C07D239/69 , C07D263/50 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04
摘要: The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors.
摘要翻译: 本发明涉及N-杂环磺酰胺化合物,特别是吡唑磺酰胺化合物,以及它们作为N-肉豆蔻酰基转移酶抑制剂的用途。
-
公开(公告)号:EP2980076A1
公开(公告)日:2016-02-03
申请号:EP15156565.2
申请日:2009-08-29
申请人: University of Dundee
发明人: Brand, Stephen , Wyatt, Paul , Thompson, Stephen , Harrison, Justin , Norcross, Neil , Gilbert, Ian , Cleghorn, Laura , Bayliss, Tracy , Smith, Victoria , Brenk, Ruth
IPC分类号: C07D213/75 , C07D231/42 , C07D239/69 , C07D263/50 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04 , A61K31/4155 , A61K31/422 , A61K31/496 , A61K31/4439 , A61K31/506 , A61P25/00 , A61P31/00 , A61P35/00
CPC分类号: C07D231/42 , A61K31/415 , C07D213/75 , C07D239/69 , C07D263/50 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D407/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D471/04 , C07D487/04
摘要: The present invention relates to N-heterocyclic sulphonamide compounds, in particular pyrazole sulphonamide compounds, and their use as N-myristoyl transferase inhibitors.
摘要翻译: 本发明涉及N-杂环磺酰胺化合物,特别是吡唑磺酰胺化合物及其作为N-肉豆蔻酰转移酶抑制剂的用途。
-
公开(公告)号:EP2385938A1
公开(公告)日:2011-11-16
申请号:EP10702740.1
申请日:2010-01-06
申请人: Pfizer Limited , ICAgen, Inc.
发明人: BEAUDOIN, Serge , LAUFERSWEILER, Michael Christopher , MARKWORTH, Christopher John , MARRON, Brian Edward , MILLAN, David Simon , RAWSON, David James , REISTER, Steven Michael , SASAKI, Kosuke , STORER, Robert Ian , STUPPLE, Paul Anthony , SWAIN, Nigel Alan , WEST, Christopher William , ZHOU, Shulan
IPC分类号: C07D263/50 , C07D277/18 , C07D285/08 , C07D413/12 , C07D417/12 , C07D275/03
CPC分类号: C07D417/12 , A61K31/427 , A61K31/433 , A61K31/4439 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/501 , A61K31/506 , A61K31/675 , A61K45/06 , C07D263/50 , C07D275/03 , C07D277/18 , C07D285/08 , C07D401/12 , C07D413/12 , C07D417/14 , C07F9/6539
摘要: The present invention relates to compounds of the formula and pharmaceutically acceptable salts, solvates or tautomers thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.
-
-
-
-
-
-
-
-
-